Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01708707 · ClinicalTrials.gov registry record · Phase 2
Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)
A Phase 2 study, sponsored by Pediatrix.
- Completed
- Registry status
- Phase 2
- Development phase
- 29
- Enrollment target
NCT01708707 is a Phase 2 study that has completed, run by Pediatrix. The registered enrollment target is 29 participants.
The verdict
NCT01708707, a Phase 2 study, has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 29 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether buprenorphine is a beneficial, safe, cost effective treatment alternative to morphine sulfate in the treatment of Neonatal Abstinence Syndrome (NAS).
Interventions
- DRUG Buprenorphine
- DRUG Morphine Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2012-12 |
| Est. Completion | 2017-10-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01708707
The ClinicalTrials.gov registry entry for NCT01708707 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pediatrix, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Buprenorphine is the first listed.
NCT01708707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01708707 about?
NCT01708707 is a clinical study titled "Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)". The purpose of the study is to determine whether buprenorphine is a beneficial, safe, cost effective treatment alternative to morphine sulfate in the treatment of Neonatal Abstinence Syndrome (NAS).
What is the current status of trial NCT01708707?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 29 participants. The study started on 2012-12. Estimated completion is 2017-10-31.
What interventions are being tested in trial NCT01708707?
The interventions under investigation include: Buprenorphine (DRUG), Morphine Sulfate (DRUG).
Who is sponsoring clinical trial NCT01708707?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.